No significant difference was found in CXCL11, IFN-γ, IL-6, and TNF-α serum levels in the CIP–MSN-treated groups relative to the unchallenged NC group (Table 2). The gene discussed is CXCL11; the disease is hereditary sensory and autonomic neuropathy.